This brand name is authorized in South Africa
The drug TITRALAC contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Calcium carbonate
UNII H0G9379FGK - CALCIUM CARBONATE
|
|
Calcium carbonate releases, in a pH-dependent manner, calcium ions in the stomach. Calcium carbonate is widely used as antacid and extensively used as a dietary supplement. |
|
2
Glycine
UNII TE7660XO1C - GLYCINE
|
|
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A02AC01 | Calcium carbonate | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids → A02AC Calcium compounds |
| A02AC10 | Combinations | A Alimentary tract and metabolism → A02 Drugs for acid related disorders → A02A Antacids → A02AC Calcium compounds |
| B05CX03 | Glycine | B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05C Irrigating solutions → B05CX Other irrigating solutions |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: ZA | Health Products Regulatory Authority | Identifier(s): E/11.4.1/552 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
